INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 103 filers reported holding INSMED INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $545 | -100.0% | 27,300 | -25.2% | 0.00% | 0.0% |
| Q4 2017 | $1,138,000 | -34.7% | 36,487 | -34.7% | 0.00% | -50.0% |
| Q3 2017 | $1,744,000 | +9.4% | 55,887 | -53.6% | 0.00% | -33.3% |
| Q4 2016 | $1,594,000 | -44.5% | 120,500 | -39.0% | 0.00% | -40.0% |
| Q3 2016 | $2,871,000 | +95.0% | 197,700 | +32.4% | 0.01% | +66.7% |
| Q2 2016 | $1,472,000 | -36.8% | 149,300 | -18.8% | 0.00% | -25.0% |
| Q1 2016 | $2,329,000 | +139.9% | 183,787 | +278.3% | 0.00% | +100.0% |
| Q2 2014 | $971,000 | – | 48,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |